ARK Investment Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $42.5M | Sell |
|
|||||
|
2022
Q3 | $261M | Buy |
|
|||||
|
2022
Q2 | $265M | Buy |
|
|||||
|
2022
Q1 | $426M | Buy |
|
|||||
|
2021
Q4 | $603M | Sell |
|
|||||
|
2021
Q3 | $646M | Buy |
|
|||||
|
2021
Q2 | $649M | Buy |
|
|||||
|
2021
Q1 | $540M | Buy |
|
|||||
|
2020
Q4 | $264M | Buy |
|
|||||
|
2020
Q3 | $57.6M | Buy |
|
|||||
|
2020
Q2 | $35M | Buy |
|
|||||
|
2020
Q1 | $12.3M | Buy |
|
|||||
|
2019
Q4 | $8.44M | Buy |
|
|||||
|
2019
Q3 | $5.26M | Buy |
|
|||||
|
2019
Q2 | $4.51M | Buy |
|